trending Market Intelligence /marketintelligence/en/news-insights/trending/858ump1mgaqaxgglwgcpea2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

UK's Oxford Nanopore Technologies planning Hong Kong, London IPOs

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

UK's Oxford Nanopore Technologies planning Hong Kong, London IPOs

Oxford Nanopore Technologies Ltd. is planning a dual listing in Hong Kong and London, the South China Morning Post reported June 18, citing CEO Gordon Sanghera.

According to the CEO, the British maker of DNA sequencing devices is targeting a Hong Kong float within 18 months, while looking at a London listing late 2019 or early 2020.

The company has held talks with Hong Kong Exchange and Clearing officials to discuss a possibility of an IPO under the city's revised listing rules, which allow biotechnology companies without a profit or revenue track record to go public.

Spun out from Oxford University in 2005, Oxford Nanopore will focus on the Chinese market, where 80% of the global projects on sequencing of new genomes of animals and plants take place, the paper noted. China is also expected to be Oxford Nanopore's biggest market for the next six to 12 months, Sanghera added.

The market for genome sequencing is dominated by Illumina Inc.

In March, Oxford Nanopore raised £100 million from global investors, including China Construction Bank's investment banking arm, CCB International, Singapore's sovereign wealth fund manager, GIC and Australia's Hostplus.

Oxford Nanopore is a portfolio company of IP Group PLC, a London-based intellectual property commercialization company.